These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23743754)

  • 1. Vestibular rehabilitation with virtual reality in Ménière's disease.
    Garcia AP; Ganança MM; Cusin FS; Tomaz A; Ganança FF; Caovilla HH
    Braz J Otorhinolaryngol; 2013; 79(3):366-74. PubMed ID: 23743754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional, virtual reality vestibular rehabilitation for chronic imbalance problem caused by Ménière's disease: a pilot study.
    Hsu SY; Fang TY; Yeh SC; Su MC; Wang PC; Wang VY
    Disabil Rehabil; 2017 Aug; 39(16):1601-1606. PubMed ID: 27418422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing function after betahistine therapy in patients with Ménière's disease.
    Seyed Tootoonchi SJ; Ghiasi S; Shadara P; Samani SM; Fouladi DF
    Braz J Otorhinolaryngol; 2016; 82(5):500-6. PubMed ID: 26810620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balance Rehabilitation Unit (BRU) posturography in Menière's disease.
    Cusin FS; Ganança MM; Ganança FF; Ganança CF; Caovilla HH
    Braz J Otorhinolaryngol; 2010; 76(5):611-7. PubMed ID: 20963345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [No Abstract]   [Full Text] [Related]  

  • 8. Betahistine or Cinnarizine for treatment of Meniere's disease.
    Djelilovic-Vranic J; Alajbegovic A; Tiric-Campara M; Volic A; Sarajlic Z; Osmanagic E; Todorovic L; Beslagic O
    Med Arch; 2012; 66(6):396-8. PubMed ID: 23409520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical management of Ménière's disease: a 10-year case series and review of literature.
    Martín González C; González FM; Trinidad A; Ibáñez A; Pinilla M; Martínez Ruiz-Coello A; Rodríguez Valiente A; López-Cortijo C
    Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1371-6. PubMed ID: 20454798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does betahistine treatment have additional benefits to vestibular rehabilitation?
    Karapolat H; Celebisoy N; Kirazli Y; Bilgen C; Eyigor S; Gode S; Akyuz A; Kirazli T
    Eur Arch Otorhinolaryngol; 2010 Aug; 267(8):1207-12. PubMed ID: 20567979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.
    Ward B; Wettstein V; Golding J; Corallo G; Nuti D; Trabalzini F; Mandala M
    J Int Adv Otol; 2019 Apr; 15(1):112-117. PubMed ID: 31058600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment in Ménière's disease: avoiding vestibular neurectomy and facilitating postoperative compensation.
    Colletti V
    Acta Otolaryngol Suppl; 2000; 544():27-33. PubMed ID: 10904798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the efficacy and safety of a new modified-release betahistine formulation in the treatment of vestibular vertigo and Meniere's disease].
    Parfenov VA; Zamergrad MV; Kazei DV; Nauta J
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):42-48. PubMed ID: 33459540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Vestibular Rehabilitation in Patients with Ménière's Disease.
    van Esch BF; van der Scheer-Horst ES; van der Zaag-Loonen HJ; Bruintjes TD; van Benthem PP
    Otolaryngol Head Neck Surg; 2017 Mar; 156(3):426-434. PubMed ID: 28112027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of betahistine on the function of equilibrium system].
    Kubiczkowa J
    Otolaryngol Pol; 1997; 51 Suppl 25():230-9. PubMed ID: 9757700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
    Nauta JJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
    Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
    J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.